Literature DB >> 26493447

The effect of surgical approach on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy.

Shane M Pearce1, Joseph J Pariser2, Sanjay G Patel2, Gary D Steinberg2, Arieh L Shalhav2, Norm D Smith2.   

Abstract

OBJECTIVES: To examine the effect of surgical approach on regional lymphadenectomy (LND) performance and inpatient complications for radical nephroureterectomy (NU) using a national administrative database.
METHODS: The National Inpatient Sample (2009-2012) was used to identify patients who underwent NU for urothelial carcinoma. Cohorts were stratified by performance of LND. Covariates included patient demographics, comorbidity, hospital characteristics, hospital volume, performance of LND, surgical approach (open [ONU], laparoscopic [LNU], or robotic [RNU]), and complications. Multivariable logistic regression was used to identify factors associated with LND performance and complications.
RESULTS: A weighted population of 14,059 (85%) without LND and 2,560 (15%) with LND was identified. LND was more common in RNU (27%) compared with ONU (15%) and LNU (10%) (P<0.01). On multivariable analysis, when compared with ONU, RNU was associated with increased odds of LND performance (odds ratio [OR] = 1.9, 95% CI: [1.3-2.8]; P = 0.001), whereas LNU was associated with decreased odds of LND performance (OR = 0.6, 95% CI: [0.4-0.8]; P = 0.004). Multivariable analysis of risk factors for complications demonstrated lower odds of complications with RNU (OR = 0.6, 95% CI: [0.4-0.8]; P = 0.001), whereas performance of LND increased the risk of complications (OR = 1.3, 95% CI: [1.001-1.7]; P = 0.049).
CONCLUSIONS: When compared with ONU, RNU increased the odds of LND performance and had a lower inpatient complication rate, whereas LNU reduced the odds of LND performance and had no significant effect on inpatient complication rates. Performance of LND was independently associated with higher inpatient complication rates.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Lymph node excision; Patterns of care; Treatment outcome; Upper urinary tract; Urothelial carcinoma

Mesh:

Year:  2015        PMID: 26493447     DOI: 10.1016/j.urolonc.2015.09.008

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  18 in total

1.  Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.

Authors:  Matthew R Danzig; Katherine Mallin; James M McKiernan; Walter M Stadler; Srikala S Sridhar; Todd M Morgan; Bernard H Bochner; Cheryl T Lee
Journal:  Cancer       Date:  2018-04-06       Impact factor: 6.860

2.  Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study.

Authors:  Fan Dong; Tianyuan Xu; Xianjin Wang; Yifan Shen; Xiaohua Zhang; Shanwen Chen; Shan Zhong; Minguang Zhang; Qiang Ding
Journal:  Int J Clin Oncol       Date:  2018-10-17       Impact factor: 3.402

3.  Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?

Authors:  Hanan Goldberg; Douglas C Cheung; Thenappan Chandrasekar; Zachary Klaassen; Christopher J D Wallis; Girish S Kulkarni; Rashid Sayyid; Andrew Evans; Mehdi Masoomian; Bharati Bapat; Theodorus van der Kwast; Robert J Hamilton; Alexandre Zlotta; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2019-01-21       Impact factor: 1.862

4.  Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).

Authors:  Meera R Chappidi; Max Kates; Michael H Johnson; Noah M Hahn; Trinity J Bivalacqua; Phillip M Pierorazio
Journal:  Urol Oncol       Date:  2016-07-27       Impact factor: 3.498

Review 5.  Frontiers in robot-assisted retroperitoneal oncological surgery.

Authors:  Wesley W Ludwig; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

6.  Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.

Authors:  Marco Moschini; Beat Foerster; Mohammad Abufaraj; Francesco Soria; Thomas Seisen; Morgan Roupret; Pierre Colin; Alexandre De la Taille; Benoit Peyronnet; Karim Bensalah; Roman Herout; Manfred Peter Wirth; Vladimir Novotny; Piotr Chlosta; Marco Bandini; Francesco Montorsi; Giuseppe Simone; Michele Gallucci; Giuseppe Romeo; Kazumasa Matsumoto; Pierre Karakiewicz; Alberto Briganti; Shahrokh F Shariat
Journal:  World J Urol       Date:  2017-02-28       Impact factor: 4.226

7.  Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?

Authors:  Sangjun Yoo; Dalsan You; In Gab Jeong; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  World J Urol       Date:  2016-08-08       Impact factor: 4.226

Review 8.  Lymph node dissection for upper tract urothelial carcinoma: A systematic review.

Authors:  Vinson Wai-Shun Chan; Chris Ho Ming Wong; Yuhong Yuan; Jeremy Yuen-Chun Teoh
Journal:  Arab J Urol       Date:  2020-07-27

9.  Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Xiaoying Li; Ming Cui; Xiaobin Gu; Dong Fang; Hongzhen Li; Shangbin Qin; Kunlin Yang; Tianzhao Zhu; Xuesong Li; Liqun Zhou; Xian-Shu Gao; Dian Wang
Journal:  World J Surg Oncol       Date:  2020-05-30       Impact factor: 2.754

Review 10.  Robot-assisted nephroureterectomy: current perspectives.

Authors:  Xin Ling Teo; Sey Kiat Lim
Journal:  Robot Surg       Date:  2016-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.